跳至主要内容
临床试验/CTRI/2019/11/022040
CTRI/2019/11/022040尚未招募4 期

Study the effect of Nitya Virechana with Trivrit and Aragvadha Churna in the management of Stage 1 Essential Hypertension

Dr Manju Mohan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex between the age group of 30-60 yrs will be selected.
  • 2.Newly detected cases of Stage 1 Essential Hypertension will be selected.
  • 3.Hypertension stage 1-SBP (130-139) or DBP (80-89) will be included for the study.

排除标准

  • 1.Hypertension associated with:
  • a.Cardio-vascular diseases
  • b.Cerebro-vascular diseases
  • c.Hypothyroidism
  • d.Diabetes Mellitus (Type 1/ Type 2/ GDM)
  • e.Pregnant and lactating women

研究者

发起方
Dr Manju Mohan

相似试验

Management of Blood Pressure by Trivrit and... | 临床试验